STOCK TITAN

Paragon 28 To Report First Quarter 2022 Financial Results on May 9, 2022, and Present at the 2022 Bank of America Healthcare Conference on May 10, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Paragon 28, Inc. (NYSE: FNA) announced it will release its Q1 2022 financial results after market close on May 9, 2022. A conference call will follow at 4:30 p.m. ET, and investors can access it by calling (844-200-6205) within the U.S. or (646-904-5544) internationally, using conference ID: 990038. CEO Albert DaCosta and CFO Steve Deitsch will also present at the Bank of America Healthcare Conference in Las Vegas on May 10, at 2:00 p.m. PT. Live webcasts will be available on the company’s website.

Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the first quarter 2022 after market close on Monday, May 9, 2022. The company’s management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing (844-200-6205) for domestic callers or (646-904-5544) for international callers, using conference ID: 990038. Live audio of the webcast will be available on the “Investors” section of the company’s website at: ir.paragon28.com. The webcast will be archived and available for replay for at least 90 days after the event.

Additionally, Albert DaCosta, Chairman and CEO, and Steve Deitsch, Chief Financial Officer, will be attending the 2022 Bank of America Healthcare Conference in Las Vegas and will be hosting a fireside chat presentation at 2:00 pm Pacific Time / 5:00 pm Eastern Time on Tuesday May 10th.

A live webcast of each event, as well as an archived recording, will be available on the “investors” section of the company’s website at: ir.paragon28.com. The webcast will be archived and available for replay for at least 90 days after the event.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Gilmartin Group

Matt Bacso, CFA

Matt.bacso@gilmartinir.com

Source: Paragon 28, Inc.

FAQ

When will Paragon 28 report its Q1 2022 financial results?

Paragon 28 will report its Q1 2022 financial results after market close on May 9, 2022.

What time is the conference call for Paragon 28's financial results?

The conference call will take place at 4:30 p.m. Eastern Time on May 9, 2022.

How can I listen to Paragon 28's conference call?

Investors can listen to the conference call by dialing (844-200-6205) for domestic calls or (646-904-5544) for international calls, using conference ID: 990038.

Where can I find the webcast of Paragon 28's events?

The live and archived webcasts will be available in the ‘Investors’ section of Paragon 28's website.

Who will represent Paragon 28 at the Bank of America Healthcare Conference?

CEO Albert DaCosta and CFO Steve Deitsch will represent Paragon 28 at the Conference.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

831.64M
49.79M
40.56%
61.27%
8.11%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD